<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="project_funders\PMC5843351\results\search\funders\results.xml">
  <result pre="acquisitionResourcesSupervisionWriting – review &amp;amp; editing1*[1], Department of Microbiology and Immunology," exact="University of North Carolina" post="at Chapel Hill School of Medicine, Chapel Hill, North"/>
  <result pre="Microbiology and Immunology, University of North Carolina at Chapel Hill" exact="School of Medicine," post="Chapel Hill, North Carolina, United States of America[2], Department"/>
  <result pre="Hill, North Carolina, United States of America[2], Department of Epidemiology," exact="University of North Carolina" post="at Chapel Hill School of Public Health, Chapel Hill,"/>
  <result pre="Public Health, Chapel Hill, North Carolina, United States of America[3]," exact="Johns Hopkins Bloomberg School of Public Health," post="Baltimore, Maryland, United States of America[4], Laboratory of Infectious"/>
  <result pre="Baltimore, Maryland, United States of America[4], Laboratory of Infectious Diseases," exact="National Institute of Allergy and Infectious Diseases," post="National Institutes of Health, Bethesda, Maryland, United States of"/>
  <result pre="of Infectious Diseases, National Institute of Allergy and Infectious Diseases," exact="National Institutes of Health," post="Bethesda, Maryland, United States of AmericaBarrettAlan D. T.Editor[], University"/>
  <result pre="of Health, Bethesda, Maryland, United States of AmericaBarrettAlan D. T.Editor[]," exact="University of Texas Medical Branch," post="UNITED STATES The authors have declared that no competing"/>
  <result pre="Diseases T32 AI1007419GallichotteEmily N. This research was supported by U.S." exact="National Institute of Allergy and Infectious Diseases" post="grants R01s AI107731 (PI: de Silva) and AI125198 (PI:"/>
  <result pre="U19 AI109761 (PI: Baric), and by grant OPP1104710 from the" exact="Bill and Melinda Gates Foundation" post="(PI: Durbin). ENG was supported by training grant T32"/>
  <result pre="supported by training grant T32 AI1007419 funding from the U.S." exact="National Institute of Allergy and Infectious Diseases." post="The funders had no role in study design, data"/>
  <result pre="were obtained from a previously described Dengue Traveler collection at" exact="University of North Carolina," post="and were all primary DENV2 natural infections [24,25,30]. Vaccine"/>
  <result pre="a live-attenuated monovalent DENV2 vaccine as developed by the US" exact="National Institutes of Health" post="(NIH) and were provided by Anna Durbin and Stephen"/>
  <result pre="used only in people previously infected with dengue. http://www.who.int/medicines/news/2017/WHO-advises-dengvaxia-used-only-in-people-previously-infected/en/. 18(2017)" exact="Sanofi" post="updates information on dengue vaccine. http://mediaroom.sanofi.com/sanofi-updates-information-on-dengue-vaccine/. 19MoodieZ, JuraskaM, HuangY,"/>
  <result pre="neutralization mechanism of a higher primate antibody against dengue virus." exact="EMBO" post="J31: 767–779. doi: 10.1038/emboj.2011.43922139356 39EndyTP (2014) Human immune responses"/>
 </snippets>
</snippetsTree>
